Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5140347 | 0.73 | — | — | |
| SCHEMBL28401629 | 0.71 | HSD17B10 (0.34) | ALDH1A1KMT2AMEN1MAPTHPGD | |
| SCHEMBL5915087 | 0.69 | HDAC3 (0.36) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL275321 | 0.69 | HDAC3 (0.36) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL15375293 | 0.69 | HDAC1 (0.33) | TSHR | |
| SCHEMBL14889184 | 0.68 | ALDH1A1 (0.36) | ALDH1A1KDM4EMAPTTSHRNPC1 | |
| Acetaldehyde SCHEMBL591968 | 0.67 | HTT (0.35) | ALDH1A1MAPTTSHRSMN1; SMN2 | |
| Octane SCHEMBL1164389 | 0.67 | HDAC1 (0.39) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL15375290 | 0.67 | HDAC1 (0.39) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL3263283 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2742080-B1 | PROCESS FOR THE PREPARATION OF POLYMERS CONTAINING BENZOHETERO [1, 3]DIAZOLE UNITS | ENI SPA (IT) | 2020-06-17 | — | — | EP | disclosed |
| US-10312395-B2 | Luminescent solar concentrator comprising disubstituted benzoheterodiazole compounds | ENI S.P.A. (IT) | 2019-06-04 | — | — | US | disclosed |
| EP-3198658-B1 | LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS | ENI SPA (IT) | 2018-12-12 | — | — | EP | disclosed |
| US-20170250300-A1 | LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS | ENI S.P.A. (IT) | 2017-08-31 | — | — | US | disclosed |
| EP-3198658-A1 | LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS | ENI S.p.A. (IT) | 2017-08-02 | — | — | EP | disclosed |
| US-9440965-B2 | Process for the synthesis of benzothiadiazole compounds | ENI S.P.A. (IT) | 2016-09-13 | — | — | US | disclosed |
| US-20150291575-A1 | PROCESS FOR THE SYNTHESIS OF BENZOTHIADIAZOLE COMPOUNDS | ENI S.P.A. (IT) | 2015-10-15 | — | — | US | disclosed |
| US-9150696-B2 | Process for the preparation of polymers containing benzohetero [1,3] diazole units | ENI S.P.A. (IT) | 2015-10-06 | — | — | US | disclosed |
| EP-2593449-B1 | PROCESS FOR THE SYNTHESIS OF BENZOTHIADIAZOLE COMPOUNDS | ENI SPA (IT) | 2015-09-09 | — | — | EP | disclosed |
| US-20140235818-A1 | PROCESS FOR THE PREPARATION OF POLYMERS CONTAINING BENZOHETERO [1,3] DIAZOLE UNITS | ENI S.P.A. (IT) | 2014-08-21 | — | — | US | disclosed |
| EP-2742080-A1 | PROCESS FOR THE PREPARATION OF POLYMERS CONTAINING BENZOHETERO [1, 3]DIAZOLE UNITS | ENI S.p.A. (IT) | 2014-06-18 | — | — | EP | disclosed |
| EP-2593449-A1 | PROCESS FOR THE SYNTHESIS OF BENZOTHIADIAZOLE COMPOUNDS | ENI S.p.A. (IT) | 2013-05-22 | — | — | EP | disclosed |
| WO-2013021314-A1 | PROCESS FOR THE PREPARATION OF POLYMERS CONTAINING BENZOHETERO [1, 3] DIAZOLE UNITS | ENI S.P.A. (IT) | 2013-02-14 | — | — | WO | disclosed |
| WO-2012007834-A1 | PROCESS FOR THE SYNTHESIS OF BENZOTHIADIAZOLE COMPOUNDS | ENI S.P.A. (IT) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170250300-A1 | LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS | SCO2, SCLY, SLC39A7 | ALDH1A1 2766/4885KMT2A 4798/4885PKM 1726/4885 |
| US-10312395-B2 | Luminescent solar concentrator comprising disubstituted benzoheterodiazole compounds | SCO2, SLC39A7, SCLY | ALDH1A1 3009/4885KMT2A 4799/4885PKM 1858/4885 |
| US-20150291575-A1 | PROCESS FOR THE SYNTHESIS OF BENZOTHIADIAZOLE COMPOUNDS | LSS, SQLE, SQOR | ALDH1A1 1065/4885KMT2A 3296/4885PKM 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.